NCT04604353View on ClinicalTrials.gov

Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring

NACompletedINTERVENTIONAL
Enrollment

1,059

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Polygenic Risk Score

Risk description to patient based on PRS

DIAGNOSTIC_TEST

Coronary Calcium Score

Risk description to patient based on CCS

Trial Locations (1)

3004

Baker Heart and Diabetes Institute, Melbourne

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER

NCT04604353 - Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring | Biotech Hunter | Biotech Hunter